T1 Tumor limited to the pancreas and size ... inhibitors may play an increasing role in the management of well-differentiated neuroendocrine tumors in the future. Peptide receptor radiotherapy ...

Your prognosis will depend on the type of pancreatic neuroendocrine cancer you have. And how far it has spread (the stage). NECs are poorly differentiated cancers. This means the cancer cells look ...

have advanced metastatic disease that has progressed on at least one prior line of available therapy and have a confirmed diagnosis of grade 3 well-differentiated neuroendocrine tumor or poorly ...

Gastrointestinal neuroendocrine ... of well-differentiated neuroendocrine tumors in the future. Peptide receptor radiotherapy is a new treatment option for patients with high tumor content of ...